ArticleStem cell research & therapy2021

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia.

Yongliang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.